After following the news flow of the biotech sphere of cancer theaupetics, diagnostics, bio markers, genetic engineering, targeted drugs, patent recognition, epigenetics and cancer antibodies for more years than I care to remember I am inform you all that the 1st April Edition of Time Magazine trumps anything I have ever read.
The insights into the future of the life science industries opportunities to firstly diagnosis and treat cancer in amazing.
I am convinced more than ever Cellmid with Midkine being its noval target is front and centre of the all planets aligning to make real progress in saving lives and eliminating the destructive nature of this disease.
Buy the Time Magazine 1st April 2013 edition and it will be the best few dollars you would of made in a while.
time magazine april 2013 1st edition
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 276424 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 424467 | 3 |
View Market Depth
| Last trade - 09.59am 25/07/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable